Since Fe causes APP to spread, RNA-based small-molecule inhibitors that target and regulate APP mRNA expression offer yet another class of therapeutic medicines that may be used to treat amyloid toxicity in AD. The gene discussed is APP; the disease is Alzheimer disease.